BOC Sciences, with its accumulated experience in liposome research, has developed a set of methods using liposomes as antigen carriers to prepare anti-low immunogenic vaccines.

For some molecules with very weak auto-immunogenicity, subdivision, glycolipids, multiples, DNA, etc., it is often difficult to achieve high specificity for the target antigen even using carrier interconnection methods to increase their immunogenicity. Liposomes have been regarded as a new type of adjuvant or vaccine implantation carrier due to their excellent antigen-stimulating activity.

https://liposomes.bocsci.com/solution/liposome-encapsulation-services-antigens.html